0000939767-20-000072.txt : 20200508 0000939767-20-000072.hdr.sgml : 20200508 20200508211431 ACCESSION NUMBER: 0000939767-20-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200507 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELDBAUM CARL B CENTRAL INDEX KEY: 0001326377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 20862366 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY, PO BOX 511 CITY: SOUTH SAN FRISCISCO STATE: CA ZIP: 94083-0511 FORMER NAME: FORMER CONFORMED NAME: Feldbaum Carl B DATE OF NAME CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_158898685314353.xml FORM 4 X0306 4 2020-05-07 0 0000939767 EXELIXIS, INC. EXEL 0001326377 FELDBAUM CARL B C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 0 0 0 Common Stock 2020-05-07 4 M 0 11546 5.82 A 20067 D Common Stock 2020-05-07 4 M 0 20000 3.38 A 40067 D Common Stock 2020-05-07 4 S 0 31546 25.02 D 8521 D Option (right to buy) 5.82 2020-05-07 4 M 0 11546 0 D 2013-12-06 2020-12-05 Common Stock 11546.0 0 D Option (right to buy) 3.38 2020-05-07 4 M 0 20000 0 D 2014-05-29 2021-05-28 Common Stock 20000.0 20000 D The option, representing the right to purchase a total of 43,546 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-05-08